key: cord-0716442-by3tm5ir
authors: Singh, Shailendra; Khan, Ahmad
title: Response to the Letters to the Editor: COVID-19 in Patients With Pre-Existing Liver Disease.
date: 2021-01-13
journal: Gastroenterology
DOI: 10.1053/j.gastro.2021.01.015
sha: bbcdc0b403c2972bf9884d7bda6fb35676468d37
doc_id: 716442
cord_uid: by3tm5ir

nan

We thank Khan et al. 1 , Verma et al. 2 , and Romana et al. 3 for their interest in our study and for highlighting several important strengths and limitations of the findings described in our study.

Ours was the first study evaluating the impact of pre-existing liver disease on COVID-19. We compared the outcomes of patients with pre-existing liver disease and without liver disease in a cohort of patients with COVID-19 in the United States. We found that patients with pre-existing liver disease were at increased risk for poor outcomes compared to patients without liver disease, and the risk was markedly higher in patients with cirrhosis.

In the letter to the editor, Khan The database currently does not allow regression analysis to adjust for confounding factors.

However, we performed propensity score matching analysis, an equally accepted method to adjust for the cofounders. Propensity matching was performed using a greedy nearestneighbor matching algorithm with a caliper of 0.1 pooled standard deviations.

We appreciate the work done by Romana et al. 3 in examining the correlation between liver chemistry abnormalities and interleukin-6 serum levels in patients with COVID-19, highlighting the role of liver injury and inflammatory state or cytokine storm during SARS-CoV-2 infection. In our study we reported elevations in liver chemistry test results from baseline values, suggesting possible liver injury from SARS-CoV-2. However, we did not study the possible reasons for the elevations in liver chemistries. We agree with Romana et al. one of the possible causes for liver function tests abnormalities can be related to cytopathic viral effect and patients with chronic liver disease could be severely affected by the cytokine storm. However, other causes should be considered, and further larger prospective studies are needed.

J o u r n a l P r e -p r o o f

Acute on Chronic Liver Failure -Possibly the main culprit of increased mortality in COVID-19 patients with liver disease

Impact of Pre-existing Chronic Liver Disease on the Outcome of Patients with COVID-19 Disease

Correlation between liver function tests abnormalities and interleukin-6 serum levels in patients with SARS-CoV-2 infection